Fortress Biotech Inc (FBIO) - Financial and Strategic SWOT Analysis Review

Fortress Biotech Inc (FBIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description - A detailed description of the company’s operations and business divisions.
Corporate strategy - Analyst’s summarization of the company’s business strategy.
SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
Company history - Progression of key events associated with the company.
Major products and services - A list of major products, services and brands of the company.
Key competitors - A list of key competitors to the company.
Key employees - A list of the key executives of the company.
Executive biographies - A brief summary of the executives’ employment history.
Key operational heads - A list of personnel heading key departments/functions.
Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Fortress Biotech Inc (Fortress Biotech), formerly Coronado Biosciences Inc, identifies, acquires, develops, and commercializes marketed pharmaceuticals and development-stage pharmaceutical product candidates. The company provides business, scientific, regulatory, and legal support for advancing the products or product candidates of its partner firms. It is a marketing partner for various branded drugs indicated for the treatment of radiation dermatitis, severe acne, athlete’s foot, inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, and other skin infections. Fortress Biotech is headquartered in New York, the US.

Fortress Biotech Inc Key Recent Developments

Dec 19, 2022: Fortress Biotech Appoints Lucy Lu, M.D., to its Board of Directors
Nov 14, 2022: Fortress Biotech Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
Oct 03, 2022: Urica Therapeutics Appoints Seasoned Biotech Executive Jay D. Kranzler, M.D., Ph.D., as Chairman and Chief Executive Officer
Sep 08, 2022: Fortress Biotech to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Section 1 - About the Company

Fortress Biotech Inc - Key Facts
Fortress Biotech Inc - Key Employees
Fortress Biotech Inc - Key Employee Biographies
Fortress Biotech Inc - Major Products and Services
Fortress Biotech Inc - History
Fortress Biotech Inc - Company Statement
Fortress Biotech Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Company Overview
Fortress Biotech Inc - Business Description
Business Segment: Dermatology Product Sales
Overview
Performance
Business Segment: Pharmaceutical and Biotechnology Product Development
Overview
Performance
R&D Overview
Fortress Biotech Inc - SWOT Analysis
SWOT Analysis - Overview
Fortress Biotech Inc - Strengths
Fortress Biotech Inc - Weaknesses
Fortress Biotech Inc - Opportunities
Fortress Biotech Inc - Threats
Fortress Biotech Inc - Key Competitors

Section 3 - Company Financial Ratios

Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances

Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
Fortress Biotech Inc, Recent Deals Summary

Section 5 - Company’s Recent Developments

Dec 19, 2022: Fortress Biotech Appoints Lucy Lu, M.D., to its Board of Directors
Nov 14, 2022: Fortress Biotech Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
Oct 03, 2022: Urica Therapeutics Appoints Seasoned Biotech Executive Jay D. Kranzler, M.D., Ph.D., as Chairman and Chief Executive Officer
Sep 08, 2022: Fortress Biotech to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
Aug 12, 2022: Checkpoint Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
Aug 11, 2022: Mustang Bio Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
Aug 11, 2022: Fortress Biotech Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
Aug 09, 2022: Journey Medical Corporation Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
Jul 22, 2022: Fortress Biotech Appoints David Jin as Chief Financial Officer
Jun 16, 2022: Checkpoint Therapeutics Announces Positive Interim Results from Registration-Enabling Trial of Cosibelimab in Locally Advanced Cutaneous Squamous Cell Carcinoma

Section 6 - Appendix

Methodology
Ratio Definitions
About the Publisher
Contact the Publisher
Disclaimer

List of Tables

Fortress Biotech Inc, Key Facts
Fortress Biotech Inc, Key Employees
Fortress Biotech Inc, Key Employee Biographies
Fortress Biotech Inc, Major Products and Services
Fortress Biotech Inc, History
Fortress Biotech Inc, Other Locations
Fortress Biotech Inc, Subsidiaries
Fortress Biotech Inc, Key Competitors
Fortress Biotech Inc, Annual Ratios
Fortress Biotech Inc, Interim Ratios
Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
Fortress Biotech Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Fortress Biotech Inc, Performance Chart (2017 - 2021)
Fortress Biotech Inc, Ratio Charts
Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
Fortress Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023